Evidence map›Paper›PMID 39085221›Full record

ArticleSchizophrenia (Heidelberg, Germany)2024

Longitudinal study on hippocampal subfields and glucose metabolism in early psychosis.

Reetta-Liina Armio, Heikki Laurikainen, Tuula Ilonen, Maija Walta, Elina Sormunen, Arvi Tolvanen, Raimo K R Salokangas, Nikolaos Koutsouleris, Lauri Tuominen, Jarmo Hietala

Erratum issuedAbstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Reetta-Liina ArmioPET Centre, Turku University Hospital, 20520, Turku, Finland. reetta-liina.armio@utu.fi.ORCID http://orcid.org/0000-0001-7245-3744
Heikki LaurikainenPET Centre, Turku University Hospital, 20520, Turku, Finland.
Tuula IlonenDepartment of Psychiatry, University of Turku, 20700, Turku, Finland.
Maija WaltaPET Centre, Turku University Hospital, 20520, Turku, Finland.
Elina SormunenPET Centre, Turku University Hospital, 20520, Turku, Finland.
Arvi TolvanenDepartment of Psychiatry, University of Turku, 20700, Turku, Finland.ORCID http://orcid.org/0009-0001-1590-0795
Raimo K R SalokangasDepartment of Psychiatry, University of Turku, 20700, Turku, Finland.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian University, D-80336, Munich, Germany.ORCID http://orcid.org/0000-0001-6825-6262
Lauri Tuominen *Department of Psychiatry, Turku University Hospital, 20520, Turku, Finland.
Jarmo Hietala *PET Centre, Turku University Hospital, 20520, Turku, Finland.ORCID http://orcid.org/0000-0002-3179-6780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Altered hippocampal morphology and metabolic pathology, but also hippocampal circuit dysfunction, are established phenomena seen in psychotic disorders. Thus, we tested whether hippocampal subfield volume deficits link with deviations in glucose metabolism commonly seen in early psychosis, and whether the glucose parameters or subfield volumes change during follow-up period using one-year longitudinal study design of 78 first-episode psychosis patients (FEP), 48 clinical high-risk patients (CHR) and 83 controls (CTR). We also tested whether hippocampal morphology and glucose metabolism relate to clinical outcome. Hippocampus subfields were segmented with Freesurfer from 3T MRI images and parameters of glucose metabolism were determined in fasting plasma samples. Hippocampal subfield volumes were consistently lower in FEPs, and findings were more robust in non-affective psychoses, with strongest decreases in CA1, molecular layer and hippocampal tail, and in hippocampal tail of CHRs, compared to CTRs. These morphometric differences remained stable at one-year follow-up. Both non-diabetic CHRs and FEPs had worse glucose parameters compared to CTRs at baseline. We found that, insulin levels and insulin resistance increased during the follow-up period only in CHR, effect being largest in the CHRs converting to psychosis, independent of exposure to antipsychotics. The worsening of insulin resistance was associated with deterioration of function and symptoms in CHR. The smaller volume of hippocampal tail was associated with higher plasma insulin and insulin resistance in FEPs, at the one-year follow-up. Our longitudinal study supports the view that temporospatial hippocampal subfield volume deficits are stable near the onset of first psychosis, being more robust in non-affective psychoses, but less prominent in the CHR group. Specific subfield defects were related to worsening glucose metabolism during the progression of psychosis, suggesting that hippocampus is part of the circuits regulating aberrant glucose metabolism in early psychosis. Worsening of glucose metabolism in CHR group was associated with worse clinical outcome measures indicating a need for heightened clinical attention to metabolic problems already in CHR.

Identifiers

PMID39085221
PMCPMC11291638

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.